Report Company Directory

ConnectOne Bancorp Inc.

• ConnectOne Bancorp, Inc. Reports Fourth Quarter and Full-Year 2025 Results by GlobeNewsWire
• ConnectOne Bancorp, Inc. to Host 2025 Fourth Quarter Results Conference Call on January 29, 2026 by GlobeNewsWire
• ConnectOne Bancorp, Inc. Reports Third Quarter 2025 Results by GlobeNewsWire
• ConnectOne Bancorp, Inc. to Host 2025 Third Quarter Results Conference Call on October 30, 2025 by GlobeNewsWire
• InsiderInsights Weekly Report: August 9, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: August 5, 2025 by InsiderInsights.com
• Connectone Bancorp Inc: 1 director by SmartInsider
• ConnectOne Bancorp, Inc. Reports Second Quarter 2025 Results; Declares Common and Preferred Dividends by GlobeNewsWire
• ConnectOne Bancorp, Inc. to Host 2025 Second Quarter Results Conference Call on July 29, 2025 by GlobeNewsWire
• ConnectOne Bancorp Strengthens Executive Leadership By Appointing Legal Advisor Robert Schwartz to General Counsel by GlobeNewsWire

CONNECTONE BANCORP INC

Connecture

• Insider bought: Two Directors bought 3,116,000 shares at 1.650USD. by SmartInsider

Connectyx Technologies Holding

• Curative Biotechnology Announces Canadian Patent Allowance by GlobeNewsWire
• Curative Biotechnology, Inc. Announces Letter to Shareholders by GlobeNewsWire
• Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor by GlobeNewsWire
• Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors by GlobeNewsWire
• Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors by GlobeNewsWire
• Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors by GlobeNewsWire
• Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions by GlobeNewsWire
• Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation by GlobeNewsWire
• Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study by GlobeNewsWire
• Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange by GlobeNewsWire

CONNEQT HEALTH LIMITED